4//SEC Filing
Lemercier Jean-Luc M 4
Accession 0001225208-24-005437
CIK 0001099800other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 5:17 PM ET
Size
10.8 KB
Accession
0001225208-24-005437
Insider Transaction Report
Form 4
Lemercier Jean-Luc M
CVP, EMEA, Canada, Latin Amer
Transactions
- Exercise/Conversion
Common Stock
2024-05-01$36.75/sh+14,400$529,200→ 188,248.806 total - Sale
Common Stock
2024-05-01$84.11/sh−12,240$1,029,449→ 173,848.806 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2024-05-01−14,400→ 0 totalExercise: $36.75From: 2018-05-11Exp: 2024-05-10→ Common Stock (14,400 underlying) - Sale
Common Stock
2024-05-01$84.83/sh−2,160$183,238→ 186,088.806 total
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 31, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $84.750 to $84.930. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $83.740 to $84.725. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001710625
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 5:17 PM ET
- Size
- 10.8 KB